February 16, 2023
February 16, 2023 —
UC San Diego researchers report that a late-stage, pre-clinical small molecule inhibitor reverses malignant hyper-editing by a protein that promotes silencing of the immune response, metastasis and therapeutic resistance in 20 different cancer types.
February 8, 2023
February 8, 2023 —
With a generous $22 million in gifts from Joan and Irwin Jacobs, UC San Diego Health will bring its Center for Health Innovation into full reality.
February 8, 2023
February 8, 2023 —
Toddlers’ level of attention to "motherese" speech can be used as a biomarker for autism spectrum disorder (ASD). UC San Diego scientists developed a new eye-tracking test to measure it, which can accurately identify toddlers with a subtype of ASD.
February 7, 2023
February 7, 2023 —
A novel drug combination for leukemia, pioneered at UC San Diego Health, provides patients with a better treatment option that results in less side effects and can put patients in remission.
February 7, 2023
February 7, 2023 —
UC San Diego Health's Center for Transplantation is among the nation's best in lung, heart, kidney and liver programs, powered by long experience and deep expertise.
February 7, 2023
February 7, 2023 —
Community health workers training program aims to increase access to health care services in underserved neighborhoods
February 6, 2023
February 6, 2023 —
A free Rescue Me CPR! app was created by UC San Diego Health’s Mark Greenberg, MD, as a tool to help combat the surge of opioid overdoses. The app uses videos and simple instructions to walk anyone through all the necessary steps to perform basic life support in real time.
February 2, 2023
February 2, 2023 —
From pandemics to health inequities, confronting future crises will look different — and that’s a good thing.
January 31, 2023
January 31, 2023 —
UC San Diego scientists developed an artificial intelligence tool that could accelerate the development of new high affinity antibody drugs.
January 31, 2023
January 31, 2023 —
In the span of just a few weeks, Don Cleveland, a leading researcher in the study of neurodegenerative diseases like ALS and Alzheimer’s, has received three major awards.